FRAZIER MANAGEMENT LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,740,000
-22.8%
1,312,2580.0%0.34%
-20.9%
Q2 2020$4,842,000
+48.8%
1,312,2580.0%0.42%
+15.2%
Q1 2020$3,254,000
-35.4%
1,312,2580.0%0.37%
-56.3%
Q4 2019$5,039,000
+92.5%
1,312,2580.0%0.84%
+3.2%
Q3 2019$2,618,000
+18.7%
1,312,2580.0%0.82%
+45.0%
Q2 2019$2,205,000
-36.6%
1,312,2580.0%0.56%
-32.5%
Q1 2019$3,477,000
+12.7%
1,312,2580.0%0.84%
+5.2%
Q4 2018$3,084,000
-46.6%
1,312,2580.0%0.80%
-24.7%
Q3 2018$5,774,000
-15.4%
1,312,2580.0%1.06%
-25.2%
Q2 2018$6,824,000
+30.0%
1,312,2580.0%1.41%
+62.3%
Q1 2018$5,249,000
-41.2%
1,312,2580.0%0.87%
-39.8%
Q4 2017$8,923,000
-16.1%
1,312,2580.0%1.45%
-61.8%
Q3 2017$10,629,000
+8.0%
1,312,2580.0%3.79%
-24.9%
Q2 2017$9,842,000
-3.8%
1,312,2580.0%5.04%
-7.7%
Q1 2017$10,236,000
-25.0%
1,312,2580.0%5.47%
-68.2%
Q4 2016$13,647,000
-9.2%
1,312,2580.0%17.18%
+133.0%
Q3 2016$15,025,000
+11.1%
1,312,2580.0%7.37%
-31.7%
Q2 2016$13,529,000
-18.8%
1,312,2580.0%10.79%
+5.2%
Q1 2016$16,666,000
-26.0%
1,312,2580.0%10.26%
+9.0%
Q4 2015$22,518,0001,312,2589.42%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders